Baker Heart and Diabetes Institute is an international leader in cardiovascular research.
Programs extend from laboratory to clinical research and wide-scale national and international community studies, with a focus on diagnosis, prevention and treatment.
Read more on Baker Institute’s cardiovascular research programs
Cardiologist and CVD researcher, Professor Karlheinz Peter heads the Baker Institute’s Atherothrombosis and Vascular Biology lab. They aim improve diagnosis and therapy of thrombotic and inflammatory diseases such as heart attack.
Other Alliance research in Cardiovascular Disease
- The Monash University Department of Epidemiology and Preventive Medicine (DEPM) is coordinating the ASPREE (ASPirin in Reducing Events in the Elderly) study. ASPREE is the largest primary prevention study ever undertaken in elderly Australians and will determine whether aspirin can help prevent or delay the onset of common age-related disease including cardiovascular disease.
- Research undertaken at the Alfred Department of Cardiovascular Medicine includes structural heart disease, acute coronary syndromes and non-invasive imaging
- Australian Centre for Blood Diseases – non-malignant haematology, including arterial thrombosis
- Monash Centre of Cardiovascular Research & Education in Therapeutics – multi-national heart failure prevention trials.
Public Health Programs
The Alliance hosts several programs for Cardiovascular Disease + Diabetes. Read about these programs on our Public Health Programs page.